Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction.
about
Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networks.Role of Thalamic Projection in NMDA Receptor-Induced Disruption of Cortical Slow Oscillation and Short-Term Plasticity.An in vivo assay of synaptic function mediating human cognition.Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism-based adverse events.The effect of ketamine-contaminated control plasma on small-molecule plasma protein binding.Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242.Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours.The role of miR-124 in modulating hippocampal neurotoxicity induced by ketamine anesthesia.Reverse and Forward Translational Neuropharmacology in Psychiatric Drug Discovery.
P2860
Q26830533-316DFB98-CF83-4D86-97E0-96EC5AA5439FQ33620630-F69AC67B-2B3E-4606-9D42-C39125C5BE6CQ34953049-03B96065-D48E-4B80-B082-47ACBDABDC73Q35157000-E00ADBE0-D7E0-43CC-A9A0-152C6189D479Q39668365-DB55FD9C-FAD4-4E5D-9074-387A050C9D74Q46139444-8B9EC050-63A9-4F86-82B6-FFE0D2844927Q47789718-BCF8D20F-3CE7-4215-8D1D-750ED86E3BFCQ47869087-74DF3B3B-7D20-4711-BEFE-90912A0A552FQ47871288-1422B220-C250-4EAC-8BB6-481ADC2EB9E7Q50094572-508FC696-4B87-4ECD-BEBD-233BA96F3F3D
P2860
Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Prevention of ketamine-induced ...... odel of cognitive dysfunction.
@en
Prevention of ketamine-induced ...... odel of cognitive dysfunction.
@nl
type
label
Prevention of ketamine-induced ...... odel of cognitive dysfunction.
@en
Prevention of ketamine-induced ...... odel of cognitive dysfunction.
@nl
prefLabel
Prevention of ketamine-induced ...... odel of cognitive dysfunction.
@en
Prevention of ketamine-induced ...... odel of cognitive dysfunction.
@nl
P2093
P1476
Prevention of ketamine-induced ...... odel of cognitive dysfunction.
@en
P2093
Brooke M Roberts
Christopher J Schmidt
Christopher L Shaffer
Daniel E Holden
Graham V Williams
Patricia A Seymour
Stacy A Castner
P356
10.1016/J.BBR.2010.03.039
P407
P577
2010-03-27T00:00:00Z